These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15364336)

  • 1. Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
    McCurley JM; Hanlon SU; Wei SK; Wedam EF; Michalski M; Haigney MC
    J Am Coll Cardiol; 2004 Sep; 44(6):1301-7. PubMed ID: 15364336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
    Weber KT
    J Am Coll Cardiol; 2004 Sep; 44(6):1308-10. PubMed ID: 15364337
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
    Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure.
    Mukherjee R; Hewett KW; Walker JD; Basler CG; Spinale FG
    Cardiovasc Res; 1998 Feb; 37(2):432-44. PubMed ID: 9614498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
    Boccanelli A; Cacciatore G; Mureddu GF; de Simone G; Clemenza F; De Maria R; Di Lenarda A; Gavazzi A; Latini R; Masson S; Porcu M; Vanasia M; Gonzini L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):683-91. PubMed ID: 17700397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.
    Osadchii OE; Woodiwiss AJ; Deftereos D; Norton GR
    Pflugers Arch; 2007 Nov; 455(2):251-60. PubMed ID: 17558518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure.
    Hebbar L; Dorman BH; Clair MJ; Roy RC; Spinale FG
    Anesthesiology; 1997 Mar; 86(3):649-59. PubMed ID: 9066332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
    Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
    J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in Na/Ca exchanger current and beta-adrenergic responsiveness in heart failure in pig myocytes.
    Wei SK; McCurley JM; Hanlon SU; Haigney MC
    Ann N Y Acad Sci; 2007 Mar; 1099():183-9. PubMed ID: 17446456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.
    Mottram PM; Haluska B; Leano R; Cowley D; Stowasser M; Marwick TH
    Circulation; 2004 Aug; 110(5):558-65. PubMed ID: 15277317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling.
    Li W; Gan R; Sun G
    Chin Med J (Engl); 2002 Aug; 115(8):1166-9. PubMed ID: 12215284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.